{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:27:27Z","timestamp":1792531647539,"version":"4.5.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K43TW011926"],"award-info":[{"award-number":["K43TW011926"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA 2019 CDF-2782"],"award-info":[{"award-number":["TMA 2019 CDF-2782"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011858","name":"African Academy of Sciences","doi-asserted-by":"crossref","award":["APTI-18-07"],"award-info":[{"award-number":["APTI-18-07"]}],"id":[{"id":"10.13039\/501100011858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts.\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    requires host glucose for survival and proliferation. On this basis,\n                    <jats:italic>P<\/jats:italic>\n                    .\n                    <jats:italic>falciparum<\/jats:italic>\n                    hexose transporter 1 (\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1) protein involved in hexose permeation is considered a potential drug target. In this study, we tested the antimalarial activity of some compounds against\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 using computational techniques. We performed high throughput virtual screening of 21,352 small-molecule compounds against\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1. The stability of the lead compound complexes was evaluated via molecular dynamics (MD) simulation for 100 nanoseconds. We also investigated the pharmacodynamic, pharmacokinetic and physiological characteristics of the compounds in accordance with Lipinksi rules for drug-likeness to bind and inhibit\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1. Molecular docking and free binding energy analyses were carried out using Molecular Mechanics with Generalized Born and Surface Area (MMGBSA) solvation to determine the selectivity of the hit compounds for\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 over the human glucose transporter (hGLUT1) orthologue. Five important\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 inhibitors were identified: Hyperoside (CID5281643); avicularin (CID5490064); sylibin (CID5213); harpagoside (CID5481542) and quercetagetin (CID5281680). The compounds formed intermolecular interaction with the binding pocket of the\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 target via conserved amino acid residues (Val314, Gly183, Thr49, Asn52, Gly183, Ser315, Ser317, and Asn48). The MMGBSA analysis of the complexes yielded high free binding energies. Four (CID5281643, CID5490064, CID5213, and CID5481542) of the identified compounds were found to be stable within the\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 binding pocket throughout the 100 nanoseconds simulation run time. The four compounds demonstrated higher affinity for\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 than the human major glucose transporter (hGLUT1). This investigation demonstrates the inhibition potential of sylibin, hyperoside, harpagoside, and avicularin against\n                    <jats:italic>Pf<\/jats:italic>\n                    HT1 receptor. Robust preclinical investigations are required to validate the chemotherapeutic properties of the identified compounds.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0268269","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T13:54:49Z","timestamp":1661522089000},"page":"e0268269","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":125,"title":["Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors"],"prefix":"10.1371","volume":"17","author":[{"given":"Afolabi J.","family":"Owoloye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funmilayo C.","family":"Ligali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojochenemi A.","family":"Enejoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesola Z.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwagbemiga","family":"Aina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-0598","authenticated-orcid":true,"given":"Emmanuel T.","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1003-2570","authenticated-orcid":true,"given":"Kolapo M.","family":"Oyebola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"pone.0268269.ref001","author":"WHO.","year":"2021","journal-title":"World malaria report 2021"},{"issue":"3","key":"pone.0268269.ref002","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.EI10-0013-2016","article-title":"Artemisinin-Resistant Plasmodium falciparum Malaria","volume":"4","author":"RM Fairhurst","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"4","key":"pone.0268269.ref003","first-page":"e00019","article-title":"Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution","volume":"32","author":"X-z Su","year":"2019"},{"issue":"16","key":"pone.0268269.ref004","first-page":"2569","article-title":"Combating multidrug\u2010resistant Plasmodium falciparum malaria.","volume":"284","author":"AM Thu","year":"2017"},{"issue":"3","key":"pone.0268269.ref005","first-page":"209","article-title":"SHJCh, microbe. Malaria parasite pre-erythrocytic stage infection: gliding and hiding","volume":"4","author":"AM Vaughan","year":"2008"},{"issue":"6","key":"pone.0268269.ref006","first-page":"a025486","volume":"7","author":"AM Vaughan","year":"2017","journal-title":"Malaria parasite liver infection and exoerythrocytic biology"},{"key":"pone.0268269.ref007","volume-title":"Computational Evaluation and Structure-based Design for Potentiation of Nicotine Vaccines","author":"KL Saylor","year":"2020"},{"issue":"5","key":"pone.0268269.ref008","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jcb.30237","article-title":"Identification of acridinedione scaffolds as potential inhibitor of DENV-2 C protein: An in silico strategy to combat dengue","volume":"123","author":"S Kumar","year":"2022","journal-title":"J Cell Biochem"},{"issue":"4","key":"pone.0268269.ref009","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4155\/fmc-2017-0151","article-title":"The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions","volume":"10","author":"M Zloh","year":"2018","journal-title":"Future Med Chem"},{"key":"pone.0268269.ref010","article-title":"Computational targeting of allosteric site of MEK1 by quinoline-based molecules","author":"R Singh","year":"2022","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"pone.0268269.ref011","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/jiv358","article-title":"A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609","volume":"213","author":"R Zhang","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"pone.0268269.ref012","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02181-19","article-title":"Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor","volume":"64","author":"M Rottmann","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 21","key":"pone.0268269.ref013","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1242\/jeb.00589","article-title":"Antimalarial drug discovery: old and new approaches","volume":"206","author":"PJ Rosenthal","year":"2003","journal-title":"J Exp Biol"},{"key":"pone.0268269.ref014","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2147\/DDDT.S265602","article-title":"Recent Progress in the Development of New Antimalarial Drugs with Novel Targets.","volume":"14","author":"TM Belete","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"pone.0268269.ref015","first-page":"79","article-title":"parasitology b. Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites","volume":"67","author":"H Atamna","year":"1994"},{"issue":"7794","key":"pone.0268269.ref016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-020-1963-z","article-title":"The molecular basis for sugar import in malaria parasites","volume":"578","author":"AA Qureshi","year":"2020","journal-title":"Nature"},{"key":"pone.0268269.ref017","first-page":"413","article-title":"Modelling. Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH","volume":"75","author":"A Manhas","year":"2017"},{"key":"pone.0268269.ref018","author":"T Althoff","year":"2020"},{"key":"pone.0268269.ref019","unstructured":"Epik S, LLC, New York, NY, 2021; Impact, Schr\u00f6dinger, LLC, New York, NY; Prime, Schr\u00f6dinger, LLC, New York, NY, 2021. Schr\u00f6dinger Release 2021\u20134: Protein Preparation Wizard. 2021."},{"issue":"8","key":"pone.0268269.ref020","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/ci400052w","article-title":"Investigation on the effect of key water molecules on docking performance in CSARdock exercise","volume":"53","author":"A Kumar","year":"2013","journal-title":"J Chem Inf Model"},{"key":"pone.0268269.ref021","unstructured":"Maestro SJNY, NY. Llc. 2017."},{"issue":"4","key":"pone.0268269.ref022","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000858","article-title":"Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family","volume":"4","author":"TF Custodio","year":"2021","journal-title":"Life Sci Alliance"},{"key":"pone.0268269.ref023","volume-title":"Schr\u00f6dinger Release 2017:","author":"LLC Epik S","year":"2017"},{"key":"pone.0268269.ref024","volume-title":"Schr\u00f6dinger Release 2021\u20133","author":"LLC Epik S","year":"2021"},{"issue":"2","key":"pone.0268269.ref025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/acs.jcim.6b00443","article-title":"Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide.","volume":"57","author":"H Alogheli","year":"2017","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0268269.ref026","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11030-021-10276-6","article-title":"In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer\u2019s disease","volume":"26","author":"S Satarker","year":"2022","journal-title":"Molecular Diversity"},{"issue":"1","key":"pone.0268269.ref027","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.","volume":"12","author":"E Harder","year":"2016","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"pone.0268269.ref028","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-3495(97)78756-3","article-title":"The statistical-thermodynamic basis for computation of binding affinities: a critical review","volume":"72","author":"MK Gilson","year":"1997","journal-title":"Biophys J"},{"issue":"34","key":"pone.0268269.ref029","first-page":"3909","article-title":"Current tools and methods in molecular dynamics (MD) simulations for drug design","volume":"23","author":"C Hern\u00e1ndez-Rodr\u00edguez M","year":"2016"},{"key":"pone.0268269.ref030","volume-title":"SC\u201906: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","author":"KJ Bowers","year":"2006"},{"issue":"3","key":"pone.0268269.ref031","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"GM Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"key":"pone.0268269.ref032","unstructured":"2021\u20134 SR. Protein Preparation Wizard. Epik, Schr\u00f6dinger, LLC, New York. 2021."},{"key":"pone.0268269.ref033","author":"P. Builder","year":"2022","journal-title":"Sytem Builder."},{"issue":"16","key":"pone.0268269.ref034","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated Modeling Program, Applied Chemical Theory (IMPACT).","volume":"26","author":"JL Banks","year":"2005","journal-title":"J Comput Chem"},{"issue":"5","key":"pone.0268269.ref035","first-page":"4177","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"GJ Martyna","year":"1994"},{"key":"pone.0268269.ref036","unstructured":"QikProp SJML, New York, USA. Schr\u00f6dinger Release 2017. 2017."},{"issue":"1\u20133","key":"pone.0268269.ref037","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"pone.0268269.ref038","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"A Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"pone.0268269.ref039","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","author":"AP Bento","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"pone.0268269.ref040","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"M Davies","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pone.0268269.ref041","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"D Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0268269.ref042","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"T Sander","year":"2015","journal-title":"J Chem Inf Model"},{"key":"pone.0268269.ref043","first-page":"31","author":"M Zheng","year":"2012","journal-title":"Involvement of serotonergic system in the antidepressant-like effect of hyperoside from Apocynum venetum leaves"},{"issue":"1\u20132","key":"pone.0268269.ref044","first-page":"97","article-title":"Application of high-speed counter-current chromatography coupled with high-performance liquid chromatography\u2013diode array detection for the preparative isolation and purification of hyperoside from Hypericum perforatum with online purity monitoring","volume":"1116","author":"T Zhou","year":"2006"},{"issue":"3","key":"pone.0268269.ref045","first-page":"727","article-title":"Protective effects of quercetin and hyperoside on renal fibrosis in rats with unilateral ureteral obstruction","volume":"8","author":"Y Yan","year":"2014"},{"issue":"6","key":"pone.0268269.ref046","first-page":"519","article-title":"Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model","volume":"42","author":"W Zhu","year":"2014"},{"issue":"1","key":"pone.0268269.ref047","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.etap.2007.08.006","article-title":"Protective effect of hawthorn extract against genotoxicity induced by cyclophosphamide in mouse bone marrow cells","volume":"25","author":"SJ Hosseinimehr","year":"2008","journal-title":"Environ Toxicol Pharmacol"},{"key":"pone.0268269.ref048","first-page":"149","article-title":"Chemistry. A pulse radiolysis study of hyperoside isolated from Hypericum mysorense","volume":"107","author":"RC Hariharapura","year":"2015"},{"key":"pone.0268269.ref049","author":"A Rutz","year":"2021","journal-title":"Open natural products research: curation and dissemination of biological occurrences of chemical structures through Wikidata"},{"issue":"21","key":"pone.0268269.ref050","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1021\/jf401154c","article-title":"Avicularin, a plant flavonoid, suppresses lipid accumulation through repression of C\/EBPalpha-activated GLUT4-mediated glucose uptake in 3T3-L1 cells","volume":"61","author":"K Fujimori","year":"2013","journal-title":"J Agric Food Chem"},{"issue":"2","key":"pone.0268269.ref051","first-page":"368","article-title":"Inhibitory effects of harpagoside on TNF-\u03b1-induced pro-inflammatory adipokine expression through PPAR-\u03b3 activation in 3T3-L1 adipocytes","volume":"76","author":"TK Kim","year":"2015"},{"issue":"16","key":"pone.0268269.ref052","first-page":"6249","article-title":"Sadhukhan SJJoBS, Dynamics. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA\u2010dependent RNA polymerase (RdRp) inhibition: an in-silico analysis","volume":"39","author":"S Singh","year":"2021"},{"issue":"6","key":"pone.0268269.ref053","first-page":"2614","article-title":"In vitro antioxidant, anti-diabetic and antilipemic potentials of quercetagetin extracted from marigold (Tagetes erecta L.) inflorescence residues","volume":"53","author":"W Wang","year":"2016"},{"key":"pone.0268269.ref054","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jmgm.2016.03.015","article-title":"Docking, QM\/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).","volume":"66","author":"AL Fonseca","year":"2016","journal-title":"J Mol Graph Model"},{"issue":"5","key":"pone.0268269.ref055","doi-asserted-by":"crossref","first-page":"e0216457","DOI":"10.1371\/journal.pone.0216457","article-title":"Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering","volume":"14","author":"MR Heitmeier","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"pone.0268269.ref056","first-page":"198","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"R Salomon\u2010Ferrer","year":"2013"},{"key":"pone.0268269.ref057","first-page":"87","article-title":"Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors","volume":"334","author":"SK Tripathi","year":"2013"},{"key":"pone.0268269.ref058","first-page":"180","article-title":"Modelling. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations","volume":"60","author":"A Shamim","year":"2015"},{"issue":"7","key":"pone.0268269.ref059","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1080\/07391102.2020.1844803","article-title":"Discovery of new promising USP14 inhibitors: computational evaluation of the thumb-palm pocket","volume":"40","author":"N Adelakun","year":"2022","journal-title":"J Biomol Struct Dyn"},{"issue":"20","key":"pone.0268269.ref060","first-page":"6237","article-title":"Target flexibility: an emerging consideration in drug discovery and design","volume":"51","author":"P Cozzini","year":"2008"},{"issue":"5","key":"pone.0268269.ref061","first-page":"593","article-title":"Why is the Plasmodium falciparum hexose transporter a promising new drug target?","volume":"7","author":"T Joet","year":"2003"},{"issue":"13","key":"pone.0268269.ref062","first-page":"7476","article-title":"Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.","volume":"100","author":"T Jo\u00ebt","year":"2003"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T13:55:43Z","timestamp":1661522143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268269"}},"subtitle":[],"editor":[{"given":"Marco","family":"Bonizzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268269","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.27.489756","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}